THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 96 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,610,000 | -6.0% | 144,619 | +6.9% | 0.01% | -16.7% |
| Q3 2016 | $4,902,000 | +59.5% | 135,265 | -0.1% | 0.01% | +50.0% |
| Q2 2016 | $3,073,000 | +43.0% | 135,449 | +18.5% | 0.00% | +33.3% |
| Q1 2016 | $2,149,000 | +27.8% | 114,300 | +11.4% | 0.00% | +50.0% |
| Q4 2015 | $1,681,000 | +57.5% | 102,583 | +5.7% | 0.00% | +100.0% |
| Q3 2015 | $1,067,000 | -15.9% | 97,093 | -0.4% | 0.00% | -50.0% |
| Q2 2015 | $1,269,000 | +5.9% | 97,491 | +41.1% | 0.00% | 0.0% |
| Q1 2015 | $1,198,000 | +17.2% | 69,071 | +0.9% | 0.00% | +100.0% |
| Q4 2014 | $1,022,000 | -35.8% | 68,488 | -0.8% | 0.00% | -50.0% |
| Q3 2014 | $1,591,000 | -27.4% | 69,013 | +0.4% | 0.00% | -33.3% |
| Q2 2014 | $2,190,000 | – | 68,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chescapmanager LLC | 1,134,718 | $23,160,000 | 2.47% |
| Baupost Group | 8,735,168 | $178,285,000 | 1.42% |
| Orbimed Advisors | 6,219,110 | $126,932,000 | 1.19% |
| CM Management, LLC | 50,000 | $1,021,000 | 0.76% |
| Tekla Capital Management LLC | 456,296 | $9,313,000 | 0.32% |
| Rock Springs Capital Management LP | 682,600 | $13,932,000 | 0.30% |
| Virtus ETF Advisers LLC | 32,871 | $671,000 | 0.28% |
| Cormorant Asset Management, LP | 550,000 | $11,226,000 | 0.25% |
| DAFNA Capital Management LLC | 41,165 | $840,000 | 0.20% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 484,206 | $9,883,000 | 0.18% |